Nephrology Dialysis Transplantation, Vol 14, Issue 6 1541-1549, Copyright © 1999 by Oxford University Press
K Honda, K Nitta, S Horita, W Yumura, H Nihei, R Nagai, K Ikeda and S Horiuchi
Background: Ultra-filtration failure is a serious
complication of long-term continuous ambulatory peritoneal dialysis (CAPD).
This complication is related to histological changes of the peritoneum,
i.e. severe interstitial fibrosis and microvascular sclerosis. Although
their pathogenesis had not been elucidated yet, advanced glycation end
products (AGEs) have been shown to accumulate in the peritoneal tissue of
CAPD patients. Methods: Peritoneal biopsy specimens
from 14 CAPD patients with low ultra-filtration (n=9) and high
ultrafiltration (n=5) capacity were immunohistochemically investigated
using a monoclonal antibody against AGEs (6D12). The severity of peritoneal
fibrosis, microvascular sclerosis and intensity of AGE accumulation were
semi-quantitatively evaluated. Peritoneal ultra-filtration capacity was
evaluated by calculating daily ultrafiltration volume per bodyweight
(UFV/BW) and D/D0 (glucose) of the peritoneal equilibration test.
Results: In all patients with low ultra-filtration,
AGE accumulated in the peritoneal fibrous tissue and microvascular walls.
Remarkably, AGE accumulated more intensely in hyalinized fibrosis of small
venular media. Extent of AGE accumulation in peritoneal interstitium and
vascular walls correlated with the progression of interstitial fibrosis
(&rgr;=0.727, P=0.0088) and vascular sclerosis (&rgr;=0.915,
P=0.001). UFV/BW was inversely correlated to interstitial fibrosis
(&rgr;=-0.660, P=0.0174), microvascular sclerosis (&rgr;=-0.671,
P=0.0155) and microvascular sclerosis (&rgr;=-0.671, P=0.0145).
Conclusions: In CAPD patients, AGE formation in the
peritoneum correlates with the development of severe interstitial fibrosis
and microvascular sclerosis, which is associated clinically with impaired
peritoneal ultra-filtration. Key words: advanced
glycation end product; continuous ambulatory peritoneal dialysis;
peritoneal fibrosis; ultra-filtration failure; vascular changes
ORIGINAL ARTICLES
Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration
Department of Medicine, Kidney Center, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162, Japan; Department of Biochemistry, Kumamoto University School of Medicine, Kumamoto, Japan; Corresponding author
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Nakao, K. Nakao, Y. Takatori, S. Kojo, J. Inoue, S. Akagi, H. Sugiyama, J. Wada, and H. Makino Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy Nephrol. Dial. Transplant., September 16, 2009; (2009) gfp479v1. [Abstract] [Full Text] [PDF] |
||||
|
|
H. Nishimura, O. Ikehara, T. Naito, C. Higuchi, and T. Sanaka EVALUATION OF TAURINE AS AN OSMOTIC AGENT FOR PERITONEAL DIALYSIS SOLUTION Perit. Dial. Int., March 1, 2009; 29(2): 204 - 216. [Abstract] [Full Text] [PDF] |
||||
|
|
S. Duman and S. Sen TECHNICAL ASPECTS IN STUDYING PERITONEAL MORPHOLOGY IN ANIMAL MODELS OF PERITONEAL DIALYSIS Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S40 - S44. [Abstract] [Full Text] [PDF] |
||||
|
|
N. Rabbani and P. J. Thornalley QUANTITATION OF MARKERS OF PROTEIN DAMAGE BY GLYCATION, OXIDATION, AND NITRATION IN PERITONEAL DIALYSIS Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S51 - S56. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Honda, C. Hamada, M. Nakayama, M. Miyazaki, A. M. Sherif, T. Harada, H. Hirano, and on behalf of the Peritoneal Biopsy Study Group of Impact of Uremia, Diabetes, and Peritoneal Dialysis Itself on the Pathogenesis of Peritoneal Sclerosis: A Quantitative Study of Peritoneal Membrane Morphology Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 720 - 728. [Abstract] [Full Text] [PDF] |
||||
|
|
K. Kaneko, C. Hamada, and Y. Tomino PERITONEAL FIBROSIS INTERVENTION Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S82 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. De Vriese, R. G. Tilton, S. Mortier, and N. H. Lameire Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2549 - 2555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sherif, M. Nakayama, Y. Maruyama, H. Yoshida, H. Yamamoto, K. Yokoyama, and M. Kawakami Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1675 - 1681. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schwenger, C. Morath, A. Salava, K. Amann, Y. Seregin, R. Deppisch, E. Ritz, A. Bierhaus, P. P. Nawroth, and M. Zeier Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-Products J. Am. Soc. Nephrol., January 1, 2006; 17(1): 199 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Agalou, N. Ahmed, R. Babaei-Jadidi, A. Dawnay, and P. J. Thornalley Profound Mishandling of Protein Glycation Degradation Products in Uremia and Dialysis J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1471 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zareie, E. D. Keuning, P. M. ter Wee, R. H. J. Beelen, and J. van den Born Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats Nephrol. Dial. Transplant., January 1, 2005; 20(1): 189 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakamura and T. Niwa Pyridoxal Phosphate and Hepatocyte Growth Factor Prevent Dialysate-Induced Peritoneal Damage J. Am. Soc. Nephrol., January 1, 2005; 16(1): 144 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaji, Y. Nakazato, N. Oshima, M. Hayashi, and T. Saruta Oxidative stress induced by iron released from transferrin in low pH peritoneal dialysis solution Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2592 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fusshoeller, M. Plail, B. Grabensee, and J. Plum Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study Nephrol. Dial. Transplant., August 1, 2004; 19(8): 2101 - 2106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Sjoland, R. Smith Pedersen, J. Jespersen, and J. Gram Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1264 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fischbach, J. Terzic, S. Chauve, V. Laugel, A. Muller, and B. Haraldsson Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children Nephrol. Dial. Transplant., April 1, 2004; 19(4): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. De Vriese, A. Flyvbjerg, S. Mortier, R. G. Tilton, and N. H. Lameire Inhibition of the Interaction of AGE-RAGE Prevents Hyperglycemia-Induced Fibrosis of the Peritoneal Membrane J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2109 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Williams, K. J. Craig, N. Topley, C. Von Ruhland, M. Fallon, G. R. Newman, R. K. Mackenzie, and G. T. Williams Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease J. Am. Soc. Nephrol., February 1, 2002; 13(2): 470 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mortier, A. S. De Vriese, J. Van de Voorde, T. P. Schaub, J. Passlick-Deetjen, and N. H. Lameire Hemodynamic Effects of Peritoneal Dialysis Solutions on the Rat Peritoneal Membrane: Role of Acidity, Buffer Choice, Glucose Concentration, and Glucose Degradation Products J. Am. Soc. Nephrol., February 1, 2002; 13(2): 480 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jones, C. J. Holmes, R. K. Mackenzie, R. Stead, G. A. Coles, J. D. Williams, D. Faict, and N. Topley Continuous Dialysis with Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids Results in a Long-Term Improvement in Ex Vivo Peritoneal Macrophage Function J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S97 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gokal Peritoneal Dialysis in the 21st Century: An Analysis of Current Problems and Future Developments J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S104 - 115. [Full Text] [PDF] |
||||
![]() |
C. M. Hoff and T. R. Shockley Peritoneal Dialysis in the 21st Century: The Potential of Gene Therapy J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. D. Vriese, S. Mortier, and N. H. Lameire Glucotoxicity of the peritoneal membrane: the case for VEGF Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2299 - 2302. [Full Text] [PDF] |
||||
![]() |
S. Ogata, N. Yorioka, and N. Kohno Glucose and Prednisolone Alter Basic Fibroblast Growth Factor Expression in Peritoneal Mesothelial Cells and Fibroblasts J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2787 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. De Vriese, S. Mortier, and N. H. Lameire Neoangiogenesis in the peritoneal membrane: does it play a role in ultrafiltration failure? Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2143 - 2145. [Full Text] [PDF] |
||||
![]() |
P. J. MARGETTS, M. KOLB, T. GALT, C. M. HOFF, T. R. SHOCKLEY, and J. GAULDIE Gene Transfer of Transforming Growth Factor-{beta}1 to the Rat Peritoneum: Effects on Membrane Function J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2029 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. LAI, F. K. LI, H. YUI LAN, S. TANG, A. W. L. TSANG, D. T. M. CHAN, and J. C. LEUNG Expression of Aquaporin-1 in Human Peritoneal Mesothelial Cells and Its Upregulation by Glucose In Vitro J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1036 - 1045. [Abstract] [Full Text] |
||||
![]() |
S. J. DAVIES, L. PHILLIPS, P. F. NAISH, and G. I. RUSSELL Peritoneal Glucose Exposure and Changes in Membrane Solute Transport with Time on Peritoneal Dialysis J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1046 - 1051. [Abstract] [Full Text] |
||||
![]() |
S. J. Davies Peritoneal solute transport--we know it is important, but what is it? Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1120 - 1123. [Full Text] [PDF] |
||||


